Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddys Laboratories informs about press release
>>
Dr. Reddy's launches Chlorthalidone Tablets in US Market
>>
USFDA completes audit of Dr. Reddy’s Andhra Pradesh facility
>>
Dr. Reddys Lab trades in green on the BSE
>>
German regulator concludes audit of Dr Reddy’s Vishakapatnam facility
>>
Dr. Reddy's Lab launches Atomoxetine Capsules in US market
>>
USFDA issues eight observations for Dr. Reddy's Duvvada plant
>>
Dr. Reddy’s Laboratories Q2 consolidated net profit climbs 70%
>>
Dr. Reddy's Lab gets approval for Aspirin, extended-release Dipyridamole Capsules
>>
Dr. Reddy’s Lab surges on the bourses
<<
<
75
76
77
...145
>
>>